CSF CONCENTRATIONS OF MORPHINE-6-GLUCURONIDE AFTER ORAL-ADMINISTRATION OF MORPHINE

被引：26

作者：

POULAIN, P

RIBON, AM

HANKS, GW

HOSKIN, PJ

AHERNE, GW

CHAPMAN, DJ

机构：

[1] ROYAL MARSDEN HOSP,LONDON SW3 6JJ,ENGLAND

[2] UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND

来源：

PAIN | 1990年 / 41卷 / 01期

关键词：

D O I：

10.1016/0304-3959(90)91116-Z

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：115 / 116

页数：2

共 7 条

[1]

AHERNE GW, 1985, LANCET, V1, P221

[2] MORPHINE-6-GLUCURONIDE HAS HIGH-AFFINITY FOR THE OPIOID RECEPTOR [J].

CHRISTENSEN, CB ;

JORGENSEN, LN .

PHARMACOLOGY & TOXICOLOGY, 1987, 60 (01) :75-76

[3]

HANKS GW, 1987, LANCET, V2, P723

[4] THE BIOAVAILABILITY AND PHARMACOKINETICS OF MORPHINE AFTER INTRAVENOUS, ORAL AND BUCCAL ADMINISTRATION IN HEALTHY-VOLUNTEERS [J].

HOSKIN, PJ ;

HANKS, GW ;

AHERNE, GW ;

CHAPMAN, D ;

LITTLETON, P ;

FILSHIE, J .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (04) :499-505

[5]

OSBORNE R, 1988, LANCET, V1, P828

[6] MORPHINE-6-GLUCURONIDE, A POTENT MU AGONIST [J].

PASTERNAK, GW ;

BODNAR, RJ ;

CLARK, JA ;

INTURRISI, CE .

LIFE SCIENCES, 1987, 41 (26) :2845-2849

[7]

SHIMOMURA K, 1971, TOHOKU J EXP MED, V105, P43

← 1 →